Oct. 16, 2009 (Business Wire) -- Levi & Korsinsky is investigating the Board of Directors of Trimeris, Inc. (“Trimeris” or the “Company”) (NasdaqGM: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Arigene Co., Ltd. ("Arigene"). Under the terms of the agreement, Trimeris shareholders will receive $3.60 in cash for each share of Trimeris they own for a total transaction value of approximately of $81 million.

The investigation concerns whether the Trimeris Board of Directors breached their fiduciary duties to Trimeris shareholders by agreeing to sell the Company for an unfair price and by agreeing to a no-solicitation provision and a $3.2 million termination fee that will all but ensure that no superior offer will ever be forthcoming. In addition, certain shareholders currently owning approximately 36% of Trimeris' outstanding common stock have entered into an agreement to tender their shares and the Company granted Arigene a top-up option that allows Arigene to purchase additional shares of Company stock, subject to certain conditions.

If you own common stock in Trimeris and wish to obtain additional information, please contact us at the number listed below or visit http://www.zlk.com/trms1.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.